Is Amdocs Ltd. overvalued or undervalued?

As of 7 April 2025, Amdocs Ltd. has moved from an expensive to a fair valuation grade. The company appears to be fairly valued at this time. Key ratios include a P/E ratio of 39, an EV to EBITDA of 25.68, and a ROE of 18.24%.
In comparison to its peers, Amdocs' P/E ratio is lower than Fortinet, Inc. at 42.14 but higher than Cognizant Technology Solutions Corp. at 16.10, indicating a mixed positioning within its competitive landscape. Notably, Amdocs' PEG ratio stands at 3.88, suggesting that growth expectations may be priced in. Recent stock performance shows Amdocs has outperformed the S&P 500 on a year-to-date basis, returning 7.98% compared to the index's 2.44%.